Impact of Right Ventricular Dysfunction on Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation

  • Nicole Karam (Geteilte/r Erstautor/in)
  • Lukas Stolz (Geteilte/r Erstautor/in)
  • Mathias Orban
  • Simon Deseive
  • Fabien Praz
  • Daniel Kalbacher
  • Dirk Westermann
  • Daniel Braun
  • Michael Näbauer
  • Michael Neuss
  • Christian Butter
  • Mohammad Kassar
  • Aniela Petrescu
  • Roman Pfister
  • Christos Iliadis
  • Matthias Unterhuber
  • Sang-Don Park
  • Holger Thiele
  • Stephan Baldus
  • Ralph Stephan von Bardeleben
  • Stefan Blankenberg
  • Steffen Massberg
  • Stephan Windecker
  • Philipp Lurz
  • Jörg Hausleiter

Beteiligte Einrichtungen

Abstract

OBJECTIVES: This study sought to assess the impact of right ventricular dysfunction (RVD) as defined by impaired right ventricular-to-pulmonary artery (RV-PA) coupling, on survival after edge-to-edge transcatheter mitral valve repair (TMVR) for severe secondary mitral regurgitation (SMR).

BACKGROUND: Conflicting data exist regarding the benefit of TMVR in severe SMR. A possible explanation could be differences in RVD.

METHODS: Using data from the EuroSMR (European Registry on Outcomes in Secondary Mitral Regurgitation) registry, this study compared the characteristics and outcomes of SMR patients undergoing TMVR, according to their RV-PA coupling, assessed by tricuspid annular plane systolic excursion-to-systolic pulmonary artery pressure (TAPSE/sPAP) ratio.

RESULTS: Overall, 817 patients with severe SMR and available RV-PA coupling assessment underwent TMVR in the participating centers. RVD was present in 211 patients (25.8% with a TAPSE/sPAP ratio <0.274 mm/mm Hg). Although all patients demonstrated significant improvement in their New York Heart Association (NYHA) functional class, there was a trend toward a lower rate of NYHA functional class I or II among patients with RVD (56.5% vs. 65.5%, respectively; p = 0.086) after TMVR. Survival rates at 1 and 2 years were lower among patients with RVD (70.2% vs. 84.0%, respectively; p < 0.001; and 53.4% vs. 73.1%, respectively; p < 0.001). On multivariate analysis, a reduced TAPSE/sPAP ratio was a strong predictor of mortality (odds ratio: 1.62; 95% confidence interval: 1.14 to 2.31; p = 0.007).

CONCLUSIONS: RVD, as shown by impairment of RV-PA coupling, is a major predictor of adverse outcome in patients undergoing TMVR for severe SMR. The often neglected functional and anatomic RV parameters should be systematically assessed when planning TMVR procedures for patients with severe SMR.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1936-878X
DOIs
StatusVeröffentlicht - 04.2021

Anmerkungen des Dekanats

Copyright © 2021. Published by Elsevier Inc.

PubMed 33582067